For the last couple of months, retail drug store shares have sold off heavily, as investors responded negatively to the steady stream of data coming from the group, showing a universally-weak sales trend.

In these tough times, consumers have not only cut their purchases of such small luxuries as cosmetics and confections, but also necessities like prescriptions. But there are now signs that the sales and profit picture for the group could be on the mend.

IN PICTURES: 10 Insurance Tips For Homeowners

CVS Reports Surprise Sales Jump
Recently, industry leader CVS Caremark (NYSE:CVS) saw its shares jump by more than 5%, following the release of quarterly results that showed a decent uptick in same-store-sales. While earnings per share for the quarter of 79 cents roughly matched expectations, same-store-sales, a key measure of retail health, rose a healthy 4.9%. (learn more about how to analyze retail stocks, see Analyzing Retail Stocks.)

Also boosting investor confidence was evidence that problems with the company's prescription drug benefits administration business may have been resolved. The unit earlier lost two major clients, accounting for about $4.8 billion in sales, but new client adds appeared to have offset much of these losses.

Negative Sales Trend Industry Wide
CVS's improvement in same-store sales stands in stark contrast to the disappointing sales trend recently reported by rival Walgreens (NYSE:WAG), which reported a 1.1% drop in the same metric against analyst's expectations of a 2.2% gain. It was second straight month that Walgreens' same-store sales have been in the negative column. Smaller pharmacy chain Rite Aid (NYSE:RAD) also hasn't been immune to the negative sales trend, recently reporting its seventh consecutive negative sales month in December.

Pharmacies Now Adopting Low Cost Prescription Plans
In both these cases, prescription sales were down, in addition to general merchandise. And that's a big problem in the pharmacy business, since many shoppers in to fill a prescription tend to buy other items before they leave the store.

But CVS seems to have found the solution to turning this trend around. The company saw its prescription sales jump after it adopted a 90-day prescription sales plan. Such bulk buying schemes are a lower cost option for many consumers and covers many generic drugs. It's a strategy that Wal-Mart (NYSE:WMT) has had in place since 2008, and one that the pharmacies have recently picked-up on. Walgreens launched its own scheme last year.

Generic Drug Windfall Ahead
Any loss in profitability resulting from this shift in prescription marketing strategy will likely be more than made up for by pending developments with generic drugs. Large numbers of branded drugs are now poised to be replaced by generics, offering pharmacies dramatically higher margins. While competition will ultimately determine how high these margins can go, most analysts covering the sector see a huge profit windfall ahead.

The Bottom Line
Matching Wal-Mart's low-cost prescription sales strategy appears to paid off for CVS and will probably stem the negative sales tide for the rest of the players in the retail drug sector. That should be enough to swing market sentiment back into the bullish camp for this group.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  2. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  3. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  4. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  6. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  7. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  8. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  9. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  10. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
RELATED FAQS
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!